For the first time since 2000, the quarterly total raised in initial public offerings (IPOs) exceeded $1 billion. There were more IPOs in every region, and the average amount raised jumped to $62 million from $54 million in Q1. Total financing also increased, but this was due almost entirely to an enormous debt financing by Amgen (Thousand Oaks, CA, USA). Venture capital financing settled back from its peak to the levels of previous quarters. Biotech stock indices continued to underperform.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lawrence, S. IPOs break $1 billion in Q2. Nat Biotechnol 25, 833 (2007). https://doi.org/10.1038/nbt0807-833
Issue Date:
DOI: https://doi.org/10.1038/nbt0807-833
